-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group Ranked Among the Top 100 Private Enterprises in the Province for 2023
Category:
发布时间：2023-10-27
【概要描述】
On October 27, the 2023 Hebei Provincial Top 100 Private Enterprises Release Conference was held in Hengshui. During the event, the Provincial Federation of Industry and Commerce unveiled a series of rankings for the province’s top 100 private enterprises. Shijiazhuang Sihua Pharmaceutical Group was included in the provincial top 100 private enterprises, the provincial top 100 private manufacturing enterprises, the provincial top 100 private enterprises in R&D investment, and the provincial top 100 private enterprises in invention patents, ranking 70th, 55th, 29th, and 12th, respectively, on these lists.
On October 27, the 2023 Hebei Provincial Top 100 Private Enterprises Release Conference was held in Hengshui. During the event, the Provincial Federation of Industry and Commerce unveiled a series of rankings for the province’s top 100 private enterprises. Shijiazhuang Sihua Pharmaceutical Group was included in the provincial top 100 private enterprises, the provincial top 100 private manufacturing enterprises, the provincial top 100 private enterprises in R&D investment, and the provincial top 100 private enterprises in invention patents, ranking 70th, 55th, 29th, and 12th, respectively, on these lists.
As a large, key, and backbone pharmaceutical enterprise in Hebei Province, Shijiazhuang Sihua Pharmaceutical has seized development opportunities by focusing on fostering smooth dual circulation between domestic and international markets, leveraging its comparative advantages to build competitive strengths, and continuously increasing R&D investment. The company has steadily advanced forward in proactive research and the development of scientific and technological innovation capabilities, with R&D efficiency and innovation outcomes ranking among the industry’s top performers. As a result, it has achieved new breakthroughs in overall scale, product mix, and quality of development. Since the beginning of this year, the company has obtained approval for 54 new products, with innovation-driven growth propelling the enterprise onto a fast track of high-quality, innovative development.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091